Casandra
Casandra Test Code QD34186Version 1 (DRAFT)
Performing Lab
Bullous Pemphigoid BP180 Antibody
Clinical Use
Order TestUse
This test detects autoantibodies specific to BP180 (a hemidesmosomal protein) in patient serum, serving as an aid in diagnosing bullous pemphigoid. Elevated anti‑BP180 IgG levels can be correlated with disease activity and may assist both initial diagnosis and monitoring of disease severity. ELISA‑based assays for BP180 provide sensitivity ranging up to ~95%, supporting clinical decision‑making in immunobullous disorders.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (ELISA)
Biomarkers
BP180
ProteinBP180 IgG antibody • Other • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1–2 mL blood
Minimum Volume
Not provided
Container
Red Top (No Additive) tube
Related Tests
Other tests from different labs that may be relevant
Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
Mayo Clinic Lab
Bullous Pemphigoid (BP180 and BP230) Antibodies, IgG by ELISA
ARUP Laboratories
BP180 and BP230 (Bullous Pemphigoid), IgG Antibodies
Labcorp
Pemphigoid Antibody Panel
ARUP Laboratories
Immunobullous Disease Antibody Panel
ARUP Laboratories
Basement Membrane Zone (Epithelial) Antibodies, IgG by IIF
ARUP Laboratories
Antiskin Autoantibodies, Quantitative
Labcorp
Basement Membrane Zone Antibody Panel
ARUP Laboratories
Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum
Mayo Clinic Lab
Desmoglein 1 and Desmoglein 3 (Pemphigus), IgG Antibodies
Labcorp